These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33467402)

  • 21. Unusual Mismatch Repair Immunohistochemical Patterns in Endometrial Carcinoma.
    Watkins JC; Nucci MR; Ritterhouse LL; Howitt BE; Sholl LM
    Am J Surg Pathol; 2016 Jul; 40(7):909-16. PubMed ID: 27186853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PD-L1 Expression in Mismatch Repair-deficient Endometrial Carcinomas, Including Lynch Syndrome-associated and MLH1 Promoter Hypermethylated Tumors.
    Sloan EA; Ring KL; Willis BC; Modesitt SC; Mills AM
    Am J Surg Pathol; 2017 Mar; 41(3):326-333. PubMed ID: 27984238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D.
    Timmerman S; Van Rompuy AS; Van Gorp T; Vanden Bempt I; Brems H; Van Nieuwenhuysen E; Han SN; Neven P; Victoor J; Laenen A; Vergote I
    Gynecol Oncol; 2020 Apr; 157(1):245-251. PubMed ID: 31980219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lessons learnt from the implementation of a colorectal cancer screening programme for lynch syndrome in a tertiary public hospital.
    Dueñas N; Navarro M; Sanjuán X; Ruiz N; Iglesias S; Matias-Guiu X; Guardiola J; Kreisler E; Biondo S; González S; Legido R; Blanco A; Navarro S; Asiain L; Santos C; Capellá G; Pineda M; Brunet J
    Cancer Epidemiol; 2023 Feb; 82():102291. PubMed ID: 36410089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mismatch Repair Protein Expression in Endometrioid Intraepithelial Neoplasia/Atypical Hyperplasia: Should We Screen for Lynch Syndrome in Precancerous Lesions?
    Lucas E; Chen H; Molberg K; Castrillon DH; Rivera Colon G; Li L; Hinson S; Thibodeaux J; Lea J; Miller DS; Zheng W
    Int J Gynecol Pathol; 2019 Nov; 38(6):533-542. PubMed ID: 30383610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of Lynch syndrome in women with mismatch repair-deficient ovarian cancer.
    Hodan R; Kingham K; Cotter K; Folkins AK; Kurian AW; Ford JM; Longacre T
    Cancer Med; 2021 Feb; 10(3):1012-1017. PubMed ID: 33369189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementing universal upfront multi-gene panel testing in endometrial cancer: From cost to practical considerations.
    Levine MD; Barrington DA; Hampel H; Goodfellow PJ; Cohn DE
    Gynecol Oncol; 2022 Sep; 166(3):538-542. PubMed ID: 35871048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying Lynch Syndrome in Women Presenting With Endometrial Carcinoma Under the Age of 50 Years.
    Anagnostopoulos A; McKay VH; Cooper I; Campbell F; Greenhalgh L; Kirwan J
    Int J Gynecol Cancer; 2017 Jun; 27(5):931-937. PubMed ID: 28498244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Missed opportunities: Genetic counseling and testing among an ethnically diverse cohort of women with endometrial cancer.
    Lee J; Gubernick LR; Brodsky AL; Fehniger JE; Levine DA; Gerber D; Asgari SA; Cantor A; Martineau JT; Ginsburg OM; Smith JA; Pothuri B
    Gynecol Oncol; 2018 Oct; 151(1):153-158. PubMed ID: 30077346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance characteristics of a brief Family History Questionnaire to screen for Lynch syndrome in women with newly diagnosed endometrial cancer.
    Eiriksson L; Aronson M; Clarke B; Mojtahedi G; Massey C; Oza AM; Gallinger S; Pollett A; Mackay H; Bernardini MQ; Ferguson SE
    Gynecol Oncol; 2015 Feb; 136(2):311-6. PubMed ID: 25529831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Somatic aberrations of mismatch repair genes as a cause of microsatellite-unstable cancers.
    Geurts-Giele WR; Leenen CH; Dubbink HJ; Meijssen IC; Post E; Sleddens HF; Kuipers EJ; Goverde A; van den Ouweland AM; van Lier MG; Steyerberg EW; van Leerdam ME; Wagner A; Dinjens WN
    J Pathol; 2014 Dec; 234(4):548-59. PubMed ID: 25111426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.
    Garg K; Leitao MM; Kauff ND; Hansen J; Kosarin K; Shia J; Soslow RA
    Am J Surg Pathol; 2009 Jun; 33(6):925-33. PubMed ID: 19238076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testing for Lynch Syndrome in Endometrial Carcinoma: From Universal to Age-Selective
    Pasanen A; Loukovaara M; Kaikkonen E; Olkinuora A; Pylvänäinen K; Alhopuro P; Peltomäki P; Mecklin JP; Bützow R
    Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of endometrial cancer abnormal MMR protein in screening Lynch-syndrome families.
    Long Q; Peng Y; Tang Z; Wu C
    Int J Clin Exp Pathol; 2014; 7(10):7297-303. PubMed ID: 25400828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and molecular characteristics of DNA mismatch repair deficient endometrial cancer in a Japanese hospital-based population.
    Yamamoto A; Yamaguchi T; Suzuki O; Ito T; Chika N; Kamae N; Tamaru JI; Nagai T; Seki H; Arai T; Tachikawa T; Akagi K; Eguchi H; Okazaki Y; Ishida H
    Jpn J Clin Oncol; 2021 Jan; 51(1):60-69. PubMed ID: 32844218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center.
    Moline J; Mahdi H; Yang B; Biscotti C; Roma AA; Heald B; Rose PG; Michener C; Eng C
    Gynecol Oncol; 2013 Jul; 130(1):121-6. PubMed ID: 23612316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Universal Testing to Identify Lynch Syndrome Among Women With Newly Diagnosed Endometrial Carcinoma.
    Cameron A; Chiarella-Redfern H; Chu P; Perrier R; Duggan MA
    J Obstet Gynaecol Can; 2020 Feb; 42(2):137-143. PubMed ID: 31679916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lost opportunities for mismatch repair (MMR) screening among minority women with endometrial cancer.
    Huang M; Hunter T; Fein LA; Galli J; George S; Schlumbrecht M; McCarter K; Sinno AK; Guido LP; Pinto A
    Sci Rep; 2021 Jun; 11(1):11712. PubMed ID: 34083606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and Pathologic Features of Hispanic Endometrial Cancer Patients With Loss of Mismatch Repair Expression.
    Kost ER; Valente PT; Lynch BA; Krishnegowda NK; Hertz AM; Hall KL; Riddle ND; Tekmal RR
    Int J Gynecol Cancer; 2016 Jul; 26(6):1129-36. PubMed ID: 27327152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identifying patients with Lynch syndrome using a universal tumor screening program in an integrated healthcare system.
    Crain PR; Zepp JM; Gille S; Jenkins L; Kauffman TL; Shuster E; Goddard KAB; Wilfond BS; Hunter JE
    Hered Cancer Clin Pract; 2022 Apr; 20(1):17. PubMed ID: 35436948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.